Zelira Therapeutics Limited announced a private placement of private placement of a convertible loan note at a price of $1,400,000 for the gross proceeds of $1,400,000 on July 1, 2024. The transaction will include participation from new investor Osagie Imasogie. Subject to shareholder approval to be sought at the upcoming 2024 Annual General Meeting, the
Loan Note will become a Convertible Loan Note with a $0.40 conversion price. The note will mature on June 28, 2026.